QA: Regulus Therapeutics Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001505512_2022_Regulus_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001505512, Regulus Therapeutics Inc

  xvar xval
0 AssetsCurrent 65,235,000
1 IntangibleAssetsNetIncludingGoodwill 83,000
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 3,136,000
4 LiabilitiesCurrent 5,227,000
5 LiabilitiesNoncurrent 8,269,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,051,075
9 ResearchAndDevelopmentExpense 20,821,132
10 remainder_Expenses -95,551
11 remainder_Revenues 3,644,917
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 68,454,000
1 Liabilities 13,496,000
2 Expenses 31,776,656
3 Revenues 3,644,917
4 StockholdersEquity 54,958,000
5 NetIncome -28,131,739
6 ComprehensiveNetIncome -28,131,739
7 BaseVar 58,685,786
8 EconomicCapitalRatiobeforeLimitedLiability 2.24
9 EconomicCapitalRatio 3.18

Edgar->Model Mapping

Feature Distribution

Change over Time